Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Activated carbon nanoparticles are nanoscale particles of activated carbon engineered to have a high surface area and porosity. They are primarily used for their exceptional adsorptive properties in biomedical applications. The mechanism of action is based on physical adsorption—activated carbon binds toxins, drugs, or other molecules via van der Waals forces and pore trapping due to its large surface area and porous structure[3][4]. In medicine, these particles have been explored as oral antidotes for poisoning (by adsorbing toxins in the gastrointestinal tract), as drug delivery vehicles (enabling targeted or controlled release), wound dressings (adsorbing exudates and bacteria), biosensors, imaging agents, and even anticancer therapies[1][2][3][5]. Their nanoscale size allows improved dispersion in biological systems compared to traditional bulk activated charcoal. However, limitations include non-specific adsorption (which can reduce absorption of co-administered drugs) and challenges with excretion from the body[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on activated carbon nanoparticles.